Cardinal Health (CAH) Q3 2012 Earnings Call May 03, 2012 8:30 am ET Executives Sally Curley - George S. Barrett - Chairman, Chief Executive Officer and Chairman of Executive Committee Jeffrey W. Henderson - Chief Financial Officer Analysts Ricky Goldwasser - Morgan Stanley, Research Division Thomas Gallucci - Lazard Capital Markets LLC, Research Division Jeffrey T. Elliott - Robert W. Baird & Co. Incorporated, Research Division Lawrence C. Marsh - Barclays Capital, Research Division David Larsen - Leerink Swann LLC, Research Division Lisa C. Gill - JP Morgan Chase & Co, Research Division Robert P. Jones - Goldman Sachs Group Inc., Research Division John Kreger - William Blair & Company L.L.C., Research Division Steven Valiquette - UBS Investment Bank, Research Division Glen J. Santangelo - Crédit Suisse AG, Research Division Charles Rhyee - Cowen and Company, LLC, Research Division John W. Ransom - Raymond James & Associates, Inc., Research Division PresentationOperator
Good day, ladies and gentlemen, and welcome to the Cardinal Health, Inc. Third Quarter 2012 Earnings Conference Call. [Operator Instructions] As a reminder, this conference is being recorded. I would now turn the conference over to your host for today, Ms. Sally Curley, Senior Vice President of Investor Relations. Ma'am, you may begin. Sally Curley Thank you, Ben, and welcome to Cardinal Health's Third Quarter Fiscal 2012 Conference Call today. We will be making forward-looking statements. The matters addressed in the statements are subject to risks and uncertainties that could cause actual results to differ materially from those projected or implied. Please refer to the SEC filings and the forward-looking statements slide at the beginning of the presentation found on the Investor page of our website for a description of risks and uncertainties.